KIF4A and neoplasm: In the survival analysis of the clinical subgroups, the survival time of the high-KIF4A group was significantly shorter than that of the low-KIF4A group in the early group (p = 0.01, Figure 3(e)), elderly and nonelderly group (p = 0.012/0.03, Figure 3(f)), endometrioid group (p = 0.023, Figure 3(g)), tumor invasion (%) < 50 group (p = 0.009, Figure 3(i)), and BMI > 30 group (p = 0.012, Figure 3(j)).